Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2024 Mar 21;30(5):1501. doi: 10.1038/s41591-024-02928-5

Author Correction: Locoregional delivery of IL-13Rα2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial

Christine E Brown 1,, Jonathan C Hibbard 1,#, Darya Alizadeh 1,#, M Suzette Blanchard 2,#, Heini M Natri 3, Dongrui Wang 1,11, Julie R Ostberg 1, Brenda Aguilar 1, Jamie R Wagner 1, Jinny A Paul 1, Renate Starr 1, Robyn A Wong 1, Wuyang Chen 1, Noah Shulkin 1, Maryam Aftabizadeh 1, Aleksandr Filippov 4, Ammar Chaudhry 5, Julie A Ressler 5, Julie Kilpatrick 6, Paige Myers-McNamara 4, Mike Chen 4, Leo D Wang 7, Russell C Rockne 2, Joseph Georges 4, Jana Portnow 8, Michael E Barish 9, Massimo D’Apuzzo 10, Nicholas E Banovich 3, Stephen J Forman 1, Behnam Badie 4
PMCID: PMC11108767  PMID: 38514871

Correction to: Nature Medicine 10.1038/s41591-024-02875-1, published online 7 March 2024.

In the version of the article initially published, two California Institute for Regenerative Medicine grant numbers, TRAN1-TR3-05641 and CLIN2-10248 (to C.E.B.), were inadvertently omitted from the Acknowledgements section and have now been added to the HTML and PDF versions of the article.


Articles from Nature Medicine are provided here courtesy of Nature Publishing Group

RESOURCES